Client: Major Medical Technology Company.
An international IVD device manufacturer required a better understanding of the Canadian molecular IVD market in order to inform its M&A strategy there.
The client required an understanding of current market share in capital equipment and test reagents across a large range of different test types.
Our Solution
- We collected both qualitative and qualitative information through surveys and interviews with Canadian medical and pathology laboratory managers.
- This data was supplemented with in depth secondary research on the current state of the Canadian IVD market, including insights on the number of molecular diagnostic labs, test volumes, and government initiatives impacting trends in IVD testing.
- We built a market model to fully scope out the market opportunity for IVD capital equipment and reagents, including current market shares among the major competitors, and current test volumes by type.
Outcome
- A model segmenting the Canadian molecular IVD market was prepared.
- A presentation summarizing key insights was also delivered.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
